The Effect of PEGylation on Drugs' Pharmacokinetic Parameters; from Absorption to Excretion. 2024

Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Until the drugs enter humans life, they may face problems in transportation, drug delivery, and metabolism. These problems can cause reducing drug's therapeutic effect and even increase its side effects. Together, these cases can reduce the patient's compliance with the treatment and complicate the treatment process. Much work has been done to solve or at least reduce these problems. For example, using different forms of a single drug molecule (like Citalopram and Escitalopram); slight changes in the drug's molecule like Meperidine and α-Prodine, and using carriers (like Tigerase®). PEGylation is a recently presented method that can use for many targets. Poly Ethylene Glycol or PEG is a polymer that can attach to drugs by using different methods and resulting sustained release, controlled metabolism, targeted delivery, and other cases. Although they will not necessarily lead to an increase in the effect of the drug, they will lead to the improvement of the treatment process in certain ways. In this article, the team of authors has tried to collect and carefully review the best cases based on the PEGylation of drugs that can help the readers of this article.

UI MeSH Term Description Entries
D010599 Pharmacokinetics Dynamic and kinetic mechanisms of exogenous chemical DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology. ADME,ADME-Tox,ADMET,Absorption, Distribution, Metabolism, Elimination, and Toxicology,Absorption, Distribution, Metabolism, and Elimination,Drug Kinetics,Kinetics, Drug,LADMER,Liberation, Absorption, Distribution, Metabolism, Elimination, and Response
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug

Related Publications

Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
April 1964, Chemical & pharmaceutical bulletin,
Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
April 1964, Chemical & pharmaceutical bulletin,
Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
April 1964, Chemical & pharmaceutical bulletin,
Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
November 1968, Chemical & pharmaceutical bulletin,
Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
November 1968, Chemical & pharmaceutical bulletin,
Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
January 1995, European journal of drug metabolism and pharmacokinetics,
Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
September 1963, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
March 1981, Chemical & pharmaceutical bulletin,
Ali Khajeei, and Salar Masoomzadeh, and Tooba Gholikhani, and Yousef Javadzadeh
October 1998, Clinical pharmacokinetics,
Copied contents to your clipboard!